# Daniel & Daniel Consulting

- Location (FDA's records): Orinda, CA
- FDA decisions: 1 (2014–2014): 1 510(k) clearance
- Product codes: OWN (1)
- Predicates its devices cite: 5 (0 its own); citations of its devices by later devices: 2 (0 its own)
- Recalls linked to its devices: 0 (0 Class I)
- Data: FDA decisions to Oct 25, 2026; recalls to Oct 12, 2026

## Firms whose devices it cites most
- Mauna Kea Technologies: 2 (https://510kreport.com/company/mauna-kea-technologies)
- Stryker Endoscopy: 1 (https://510kreport.com/company/stryker-endoscopy)
- Richard Wolf Medical Instruments Corp.: 1 (https://510kreport.com/company/richard-wolf-medical-instruments)
- Lumenis, Inc.: 1 (https://510kreport.com/company/lumenis)

## Firms that cite its devices most
- Mauna Kea Technologies: 2 (https://510kreport.com/company/mauna-kea-technologies)

## Its most-cited devices
- K132389: Cellvizio 100 Series System and Cellvizio System with Confocal Miniprobes; Uroflex B and Cystolflex F (Both Trade Marked (2014), cited by 2

## Recent decisions
- K132389: Cellvizio 100 Series System and Cellvizio System with Confocal Miniprobes; Uroflex B and Cystolflex F (Both Trade Marked (Feb 25, 2014)

Source page: https://510kreport.com/company/daniel-daniel-consulting